These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3801960)

  • 1. [The use of aminosides in the burn patient].
    Galizia JP; Besse MD; Goldstein P; Marson JC; Crépy A; Pellerin P
    Cah Anesthesiol; 1986 Oct; 34(6):495-9. PubMed ID: 3801960
    [No Abstract]   [Full Text] [Related]  

  • 2. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in antimicrobial therapy.
    Parry MF
    Del Med J; 1978 Jan; 50(1):33-8. PubMed ID: 631383
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical view of aminoglycoside antibiotics].
    Lüthy R
    Adv Clin Pharmacol; 1978; 15():119-26. PubMed ID: 676870
    [No Abstract]   [Full Text] [Related]  

  • 7. [Netilmicin in comparison with tobramycin in the therapy of severe infections in nephropathic patients].
    Chiarini C; Marchesi E; Rigotti A; Spongano M; Galleri C
    Minerva Urol Nefrol; 1985; 37(1):29-33. PubMed ID: 4049190
    [No Abstract]   [Full Text] [Related]  

  • 8. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS; Opal S; Kopecko DJ
    Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of tobramycin on the bacterial flora of burn wounds].
    Zietkiewicz W; Nasiłowski W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Grochowska A
    Pol Tyg Lek; 1981 Aug; 36(32):1239-41. PubMed ID: 7322940
    [No Abstract]   [Full Text] [Related]  

  • 10. Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
    Matzke GR; Millikin SP; Kovarik JM
    Clin Pharm; 1989 Nov; 8(11):800-6. PubMed ID: 2805631
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical netilmicin compared with tobramycin in the treatment of external ocular infection.
    Milazzo G; Papa V; Carstocea B; Chercota G; Rodica P; Gafencu O; Santocono M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):243-8. PubMed ID: 10363623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt infections: prevention and treatment.
    Chapman PH; Borges LF
    Clin Neurosurg; 1985; 32():652-64. PubMed ID: 3905157
    [No Abstract]   [Full Text] [Related]  

  • 13. [The basic principles of the antibiotic therapy of burn patients].
    Leseva M; Khadzhiĭski O; Grigorov G; Dimitrova A
    Khirurgiia (Sofiia); 1995; 48(3):8-11. PubMed ID: 8667589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontuberculous mycobacterium infection in a burn ICU patient.
    Boyer JM; Blatz PJ; Akers KS; Okulicz JF; Chung KK; Renz EM; Hospenthal DR; Murray CK
    Burns; 2010 Nov; 36(7):e136-9. PubMed ID: 20594758
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infections in burn injuries. Clinical findings, colonization and treatment].
    Flesland O; Pitkänen J
    Tidsskr Nor Laegeforen; 1987 Feb; 107(5):464-6. PubMed ID: 3576532
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
    Scheife RT; Tally FP; McGowan K; Gorbach SL
    Am J Hosp Pharm; 1981 Oct; 38(10):1466-9. PubMed ID: 7294038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin. A new aminoglycoside in the treatment of septic burn patients.
    Munster AM
    Arch Surg; 1979 Jan; 114(1):28-30. PubMed ID: 758874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobramycin--a brief review of worldwide experience.
    Speirs CF
    Del Med J; 1976 Aug; 48(8NA-NA-760902-760909):468-3. PubMed ID: 964414
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of tobramycin in an internal medicine and nephrology service].
    Dequiedt P; Vanhille P; Tacquet A
    Lille Med; 1976 Apr; 21(4 Suppl 2):389-92. PubMed ID: 957858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.